Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lidocaine for Postoperative Pain in Hepatectomy
NCT04295330Completed
- Sponsor
- West China Hospital of Sichuan University
- Start
- Feb 2020
- Primary completion
- May 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial in postoperative pain comparing Lidocaine group with Placebo group (2 arms). Primary endpoint: Incidence of moderate to severe pain (NRS ≥ 4) during movement at 24 hours. Started Feb 2020; status: completed.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT04295330.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04295330.